172 related articles for article (PubMed ID: 19219613)
1. Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness.
Wang GC; Hsieh PS; Hsu HH; Sun GH; Nieh S; Yu CP; Jin JS
World J Urol; 2009 Aug; 27(4):557-63. PubMed ID: 19219613
[TBL] [Abstract][Full Text] [Related]
2. Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.
Tsai WC; Sheu LF; Nieh S; Yu CP; Sun GH; Lin YF; Chen A; Jin JS
World J Urol; 2007 Mar; 25(1):73-80. PubMed ID: 17021824
[TBL] [Abstract][Full Text] [Related]
3. Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters.
Lee YY; Yu CP; Lin CK; Nieh S; Hsu KF; Chiang H; Jin JS
Dis Markers; 2009; 26(1):9-18. PubMed ID: 19242064
[TBL] [Abstract][Full Text] [Related]
4. Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness.
Jin JS; Yu CP; Sun GH; Lin YF; Chiang H; Chao TK; Tsai WC; Sheu LF
Histol Histopathol; 2006 Dec; 21(12):1287-93. PubMed ID: 16977579
[TBL] [Abstract][Full Text] [Related]
5. Expression of serine protease matriptase in renal cell carcinoma: correlation of tissue microarray immunohistochemical expression analysis results with clinicopathological parameters.
Jin JS; Chen A; Hsieh DS; Yao CW; Cheng MF; Lin YF
Int J Surg Pathol; 2006 Jan; 14(1):65-72. PubMed ID: 16501837
[TBL] [Abstract][Full Text] [Related]
6. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
[TBL] [Abstract][Full Text] [Related]
7. Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma.
Matsuo T; Miyata Y; Watanabe S; Ohba K; Hayashi T; Kanda S; Sakai H
Urology; 2011 Aug; 78(2):476.e9-15. PubMed ID: 21696810
[TBL] [Abstract][Full Text] [Related]
8. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
9. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
[TBL] [Abstract][Full Text] [Related]
10. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression in renal cell carcinoma.
Zamparese R; Pannone G; Santoro A; Lo Muzio L; Corsi F; Pedicillo MC; Scillitani EL; Tortorella S; Staibano S; Piscuoglio S; Lo Russo L; Bufo P
Cancer Invest; 2008 Nov; 26(9):929-35. PubMed ID: 19034775
[TBL] [Abstract][Full Text] [Related]
12. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
[TBL] [Abstract][Full Text] [Related]
13. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
[TBL] [Abstract][Full Text] [Related]
14. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.
Mahotka C; Krieg T; Krieg A; Wenzel M; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Int J Cancer; 2002 Jul; 100(1):30-6. PubMed ID: 12115583
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
Ahmed EA; Youssif ME
J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.
Lei Y; Geng Z; Guo-Jun W; He W; Jian-Lin Y
Mol Cell Biochem; 2010 Nov; 344(1-2):23-31. PubMed ID: 20563741
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
19. Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.
Strojan Fležar M; Gutnik H; Jeruc J; Kirbiš IS
Virchows Arch; 2011 Dec; 459(6):607-14. PubMed ID: 22052200
[TBL] [Abstract][Full Text] [Related]
20. Fructose transporter GLUT5 expression in clear renal cell carcinoma.
Medina Villaamil V; Aparicio Gallego G; Valbuena Rubira L; García Campelo R; Valladares-Ayerbes M; Grande Pulido E; Victoria Bolós M; Santamarina Caínzos I; Antón Aparicio LM
Oncol Rep; 2011 Feb; 25(2):315-23. PubMed ID: 21165569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
